Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neuropathy typically characterised by symmetrical involvement, and proximal as well as distal muscle weakness (typical ...

Michael Klim is plotting his return to Australia. The Olympic gold medallist has been living in Bali for more than a decade, ...

Neuropathic pain in diabetic polyneuropathy is dynamic over time, with distinct clinical and sensory predictors associated ...

Champion swimmer Michael Klim has revealed his “favourite things” are “out of the question” as he continues to battle a rare ...

MENLO PARK, CA, USA I May 14, 2025 I Nuvig Therapeutics, Inc. (“Nuvig”), a privately held biotechnology company developing novel immunomodulatory therapeutics ...

A San Antonio woman passionate about teaching special education with the North East Independent School District had to retire ...

Nuvig Therapeutics has dosed the first subject in its multi-centre Phase II INVGOR trial of recombinant human immunoglobulin ...

Top-line MaGic results anticipated in September 2025 to be the first of three catalysts for the DNTH103 neuromuscular franchise by YE'26 Phase 3 CAPTIVATE trial of DNTH103 in Chronic Inflammatory ...

Members of the European Parliament, researchers, patient advocates, national experts, and representatives from the biotech ...

We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take a look at where argenx SE (NASDAQ:ARGX) stands against other best cancer ...

Despite the Q1 miss, management reiterated confidence in its long-term “Vision 2030” strategy, highlighting strong Vyvgart uptake in gMG and CIDP and the recent U.S. approval of a self-injection ...